Literature DB >> 34373539

Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic.

Hessa Al-Kandari1,2, Dalia Al-Abdulrazzaq1,3, Lena Davidsson1, Rasheeba Nizam4, Sindhu Jacob4, Motasem Melhem4, Sumi Elsa John4, Fahd Al-Mulla5.   

Abstract

Genetic variants responsible for Maturity-Onset-Diabetes of the Young (MODY) in Kuwait were investigated. A newly established a National Referral Clinic, the Dasman Diabetes Institute (DDI-NRC), assessed forty-five members from 31 suspected MODY families by whole exome sequencing. Thirty-three of the 45 samples were independently sequenced at the DDI-NRI, Exeter University, UK ( https://www.diabetesgenes.org/ ) using targeted 21-gene panel approach. Pathogenic mutations in GCK, HNF1A, HNF1B, HNF4A, and PDX1 confirmed MODY in 7 families, giving an overall positivity rate of 22.6% in this cohort. Novel variants were identified in three families in PDX1, HNF1B, and HNF1B. In this cohort, Multiplex Ligation-dependent Probe Amplification assay did not add any value to MODY variant detection rate in sequencing negative cases. In highly selected familial autoantibody negative diabetes, known MODY genes represent a minority and 77.3% of the familial cases have yet to have a causal variant described.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34373539     DOI: 10.1038/s41598-021-95552-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

1.  Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database.

Authors:  W L Awa; E Schober; S Wiegand; J Herwig; T Meissner; F Schmidt; E Molz; R W Holl
Journal:  Diabetes Res Clin Pract       Date:  2011-09-28       Impact factor: 5.602

2.  De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.

Authors:  Juraj Stanik; Petra Dusatkova; Ondrej Cinek; Lucia Valentinova; Miroslava Huckova; Martina Skopkova; Lenka Dusatkova; Daniela Stanikova; Mikulas Pura; Iwar Klimes; Jan Lebl; Daniela Gasperikova; Stepanka Pruhova
Journal:  Diabetologia       Date:  2013-12-10       Impact factor: 10.122

3.  Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes.

Authors:  A M Møller; L T Dalgaard; F Pociot; J Nerup; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  1998-12       Impact factor: 10.122

4.  ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents.

Authors:  Andrew T Hattersley; Siri A W Greeley; Michel Polak; Oscar Rubio-Cabezas; Pål R Njølstad; Wojciech Mlynarski; Luis Castano; Annelie Carlsson; Klemens Raile; Dung V Chi; Sian Ellard; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

5.  Genetic cause of hyperglycaemia and response to treatment in diabetes.

Authors:  Ewan R Pearson; Bryan J Starkey; Roy J Powell; Fiona M Gribble; Penny M Clark; Andrew T Hattersley
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

6.  Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.

Authors:  A Paul Lambert; Sian Ellard; Lisa I S Allen; Ian W Gallen; Kathleen M Gillespie; Polly J Bingley; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

Review 7.  MODY: history, genetics, pathophysiology, and clinical decision making.

Authors:  Stefan S Fajans; Graeme I Bell
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

8.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.

Authors:  Elisa De Franco; Sarah E Flanagan; Jayne A L Houghton; Hana Lango Allen; Deborah J G Mackay; I Karen Temple; Sian Ellard; Andrew T Hattersley
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

Review 9.  Precision diabetes: learning from monogenic diabetes.

Authors:  Andrew T Hattersley; Kashyap A Patel
Journal:  Diabetologia       Date:  2017-03-17       Impact factor: 10.122

10.  Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial.

Authors:  Jeffrey W Kleinberger; Kenneth C Copeland; Rachelle G Gandica; Morey W Haymond; Lynne L Levitsky; Barbara Linder; Alan R Shuldiner; Sherida Tollefsen; Neil H White; Toni I Pollin
Journal:  Genet Med       Date:  2017-10-12       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.